Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres
gb, it (code pays fourni par la source)
5 citations
JAMA Oncology
Nikhil Babu Oommen
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
32Publications signalées
3003Citations signalées
0Affiliations récentes
Les domaines associés
Prostate Cancer Treatment and ResearchCancer Cells and MetastasisProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and ApplicationsAdvanced Radiotherapy Techniques
Les publications récentes
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
Chris Parker, Noel W. Clarke, Adrian Cook, Howard Kynaston et autres
gb, ca, dk (code pays fourni par la source)
53 citations
The Lancet
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)
Chris Parker, René Horsleben Petersen, Adrian Cook, Noel W. Clarke et autres
gb, dk, ca, ie, us (code pays fourni par la source)
54 citations
Annals of Oncology
Data from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Figure 5 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Figure 4 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Tables 5-8 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Figure Legends 1-5 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Tables 1-4 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Figures 1-3 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Tables 1-4 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
Supplementary Figure 5 from Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard, Joost F. Swennenhuis, David Olmos, Alison Reid et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.